(Q33336740)

English

Toxicity and response evaluation of the interferon inducer poly ICLC administered at low dose in advanced renal carcinoma and relapsed or refractory lymphoma: a report of two clinical trials of the Eastern Cooperative Oncology Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 July 2017

Toxicity and response evaluation of the interferon inducer poly ICLC administered at low dose in advanced renal carcinoma and relapsed or refractory lymphoma: a report of two clinical trials of the Eastern Cooperative Oncology Group (English)

1 reference

Europe PubMed Central

25 July 2017

renal carcinoma

1 reference

based on heuristic

inferred from title

Peter H. Wiernik

4

object named as

P H Wiernik

1 reference

Europe PubMed Central

25 July 2017

author name string

B J Giantonio

1

1 reference

Europe PubMed Central

25 July 2017

H Hochster

2

1 reference

Europe PubMed Central

25 July 2017

R Blum

3

1 reference

Europe PubMed Central

25 July 2017

G R Hudes

5

1 reference

Europe PubMed Central

25 July 2017

J Kirkwood

6

1 reference

Europe PubMed Central

25 July 2017

D Trump

7

1 reference

Europe PubMed Central

25 July 2017

M M Oken

8

1 reference

Europe PubMed Central

25 July 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

25 July 2017

Investigational New Drugs

1 reference

Europe PubMed Central

25 July 2017

19

1 reference

Europe PubMed Central

25 July 2017

89-92

1 reference

Europe PubMed Central

25 July 2017

1

1 reference

Europe PubMed Central

25 July 2017

https://scigraph.springernature.com/pub.10.1023/a:1006458232384

0 references

Interferon Induction in Cynomolgus and Rhesus Monkeys After Repeated Doses of a Modified Polyriboinosinic-Polyribocytidylic Acid Complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial clinical trials in cancer patients of polyriboinosinic-polyribocytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly(ICLC)], a highly effective interferon inducer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of a complex polyriboinosinic-polyribocytidylic acid with poly-L-lysine and carboxymethyl cellulose in the treatment of children with acute leukemia and neuroblastoma: a report from the Children's Cancer Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1006458232384

1 reference

Europe PubMed Central

25 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33336740&oldid=1622112843"